Moderna Inc (MRNA)

Working capital turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Revenue (ttm) US$ in thousands 6,758,000 9,088,000 10,654,000 15,059,000 19,263,000 21,390,000 22,995,000 22,600,000 18,471,000 11,831,000 7,019,000 2,732,000 803,000 246,055 106,101 52,184 60,209 81,575
Total current assets US$ in thousands 10,325,000 10,799,000 10,599,000 12,122,000 13,431,000 14,297,000 13,563,000 16,350,000 16,071,000 13,425,000 10,969,000 11,703,000 6,298,000 3,577,210 2,796,740 1,249,940 1,128,800 1,094,470 1,097,420 1,140,830
Total current liabilities US$ in thousands 3,015,000 4,385,000 3,123,000 3,499,000 4,923,000 6,807,000 6,812,000 9,238,000 9,128,000 9,957,000 8,840,000 8,441,000 4,389,000 1,473,560 161,647 134,582 143,115 147,842 161,987 159,159
Working capital turnover 0.92 1.42 1.43 1.75 2.26 2.86 3.41 3.18 2.66 3.41 3.30 0.84 0.42 0.12 0.04 0.05 0.06 0.09

December 31, 2023 calculation

Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $6,758,000K ÷ ($10,325,000K – $3,015,000K)
= 0.92

Working capital turnover is a financial ratio that measures a company's efficiency in using its working capital to generate sales revenue over a specific period. A higher working capital turnover ratio indicates that a company is effectively managing its working capital to support its revenue generation activities.

Analyzing the working capital turnover data for Moderna Inc over the past eight quarters, we observe a fluctuating trend in the ratio. In Q4 2023, the working capital turnover ratio was 0.94, indicating that the company generated $0.94 in sales for every dollar of working capital invested. This was a decrease compared to the previous quarter, Q3 2023, where the ratio was 1.42.

The increase in the working capital turnover ratio from Q4 2022 (2.26) to Q1 2022 (3.18) suggests that Moderna Inc improved its efficiency in utilizing working capital to drive sales during that period. However, the ratio has since declined over the subsequent quarters, indicating potential challenges in efficiently managing working capital.

The trend of decreasing working capital turnover ratios from Q1 2023 (1.75) to Q4 2023 (0.94) may imply that Moderna Inc is facing difficulties in optimizing its working capital to support revenue generation. It is essential for the company to closely monitor and address factors affecting its working capital efficiency to enhance profitability and financial performance in the future.


Peer comparison

Dec 31, 2023


See also:

Moderna Inc Working Capital Turnover (Quarterly Data)